Silk Therapeutics
2013
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Series A3
LATEST DEAL TYPE
$11M
LATEST DEAL AMOUNT
12
INVESTORS
Description
Manufacturer and seller of skin-care products. The company develops, manufactures and sells silk-based medical and consumer health products using minimal, highly-concentrated ingredients enabling it to bring positive change in the skincare industry and in the lives of consumers.
Website
Formerly Known As
Silk Cosmetics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Personal Products
Primary Office
- 196 Boston Avenue
- Suite 1100
- Medford, MA 02155
- United States
+1 (866) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Silk Therapeutics’s full profile, request a free trial.
Silk Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC (Series A3) | 28-Sep-2017 | $11M | 000.00 | 0000 | Completed | Generating Revenue |
| 4. Early Stage VC (Series A2) | 02-Feb-2016 | 000 | 000.00 | 000.00 | Completed | Generating Revenue |
| 3. Early Stage VC (Series A1) | 06-May-2015 | 000 | 00.000 | 0000 | Completed | Generating Revenue |
| 2. Early Stage VC (Series A1) | 27-Aug-2014 | $2M | $4.25M | 0000 | Completed | Generating Revenue |
| 1. Early Stage VC (Series A) | 24-Mar-2014 | $1.2M | $1.2M | 00.000 | Completed | Generating Revenue |
Silk Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A3 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A1 | 4,066,664 | $0.000010 | $0.06 | $0.75 | $0.75 | 1x | $0.75 | 15.27% |
| Series A | 3,535,296 | $0.000010 | $0.03 | $0.34 | $0.34 | 1x | $0.34 | 13.28% |
Silk Therapeutics Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Lear | Corporation | Minority | 000 0000 | 000000 0 | ||
| Porchlight Equity | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| BML Group | Other | Minority | 000 0000 | 000000 0 | ||
| Erin Donahue | Angel (individual) | Minority | 000 0000 | 000000 0 | ||
| Richard Sackler | Angel (individual) | Minority | 000 0000 | 000000 0 |
Silk Therapeutics Executive Team (3)
Silk Therapeutics Board Members (7)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Brendan O'Leary Ph.D | Self | Board Member | 000 0000 | |
| Daniel Kraft | The Kraft Family Foundation | Board Member | 000 0000 | |
| Gregory Altman Ph.D | Silk Therapeutics | Co-Founder, Board Member & Chief Executive Officer | 000 0000 | |
| Jeffrey Vinik | Self | Board Member | 000 0000 | |
| Roy Disney | Silk Therapeutics | Board Member | 000 0000 |
1 Former Board Member
You’re viewing 5 of 7 board members. Get the full list »